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A R T I C L E I N F O A B S T R A C T
Food allergen-specific sublingual immunotherapy (FA-SLIT) is a novel, safe and effective approach in dogs with
adverse food reactions (AFR) to reduce their clinical symptoms. However, little is known about the specific im-
mune components which mediate this reduction in clinical symptoms. In humans, regulatory T cells seem to play
an important role in this desensitisation process. Here, we investigated changes in peripheral T cell responses of
dogs with AFR upon FA-SLIT. Five dogs received a dose escalation of FA-SLIT over a six-month period. An oral
food challenge was performed at the beginning and end of the study to assess the efficacy of the FA-SLIT. Using in
vitro allergen-recall assays, we assessed the proliferation of T cell subsets before and at the end of the treatment.
FA-SLIT significantly increased the percentage of proliferating CD4-CD8- double-negative (DN) T cells, while
the percentage of allergen-specific CD4-CD8+ and CD4+CD8+ double-positive (DP) T cells decreased upon
treatment. These findings indicate that sublingual immunotherapy in dogs activates DN T cells, which might be
important for the desensitisation of dogs with adverse food reactions. However, further research is needed to
corroborate these findings and to further elucidate the mechanism of action of FA-SLIT in dogs with AFR.
1. Introduction
Currently, the only known treatment for adverse food reactions
(AFR) is avoidance of offending allergens and administration of anti-in-
flammatory medications on accidental exposure. Given the prevalence
of AFR and the significant impairment in the quality of life for both
dogs and owners, the development of a safe and efficacious therapy
targeting AFR is highly desirable. Sublingual immunotherapy (SLIT)
is a novel approach used in the treatment of people with food al-
lergy by inducing desensitisation and eventually tolerance (Kim et al.,
2011). With SLIT, small amounts of allergen extract are delivered sub-
lingually as drops or tablets. Although the exact mechanisms of de-
sensitisation with allergen-specific immunotherapy are still not fully
understood, it is known that skewing of T-cell responses from aller-
gen-specific effector T cells toward regulatory T cells (Tregs) is an es-
sential event in the development of normal immune responses to al-
lergens and is correlated with successful allergen-specific immunother-
apy (ASIT) in humans (Akdis et al., 1998). There are numerous stud-
ies on immunotherapy for food allergy in humans,
but studies in veterinary medicine on the efficacy of immunotherapy in
the context of allergies and the immune components involved are lack-
ing. We have recently reported that FA-SLIT had a favourable safety
profile and was associated with decreased pruritus and clinical signs in
dogs with AFR (Maina et al., 2016; Maina and Cox, 2016). Moreover,
we showed that FA-SLIT triggered IL-10 secretion upon stimulation of
PBMCs with allergens (Maina et al., 2017). In the present study, we
aimed to investigate if these clinical improvements were accompanied
by changes in the allergic immune response and more specific if FA-SLIT
might modulate the response of specific T cell subsets upon stimulation
with allergens.
2. Materials and methods
2.1. Animals and sampling
Client-owned dogs were enrolled as reported previously (Maina and
Cox, 2016). Briefly, dogs with proven AFR and no other concurrent al-
lergic conditions were randomized to receive the treatment (T group)
with FA-SLIT (n=5). During the study dogs were fed a restrictive
diet. Clinical signs were provoked by feeding the diet con
⁎ Corresponding author.
Email address: eric.cox@ugent.be (E. Cox)
https://doi.org/10.1016/j.vetimm.2019.05.003












E. Maina et al. Veterinary Immunology and Immunopathology xxx (xxxx) xxx-xxx
taining the suspected allergen before and at the end of the study. The
severity of clinical signs was assessed with a pruritus Visual Analog
Scale (pVAS) and the fourth iteration of the Canine Atopic Dermatitis
Extent and Severity Index (CADESI-04) (Hill et al., 2007; Olivry et al.,
2014). The treatment was continued daily for at least six months with
dose escalations every two weeks. Peripheral blood samples were col-
lected by cephalic or jugular venipuncture during the two provocative
food exposure phases (before and after treatment). Sera were frozen at -
20 °C until tested.
2.2. IgE ELISA
Serum food allergen-specific IgE concentrations were evaluated by
ELISA. Allergen extracts (pork, chicken, beef, cow’s milk, fish, rice,
wheat and corn) were coated on 96-well plates (Nunc MaxiSorp®)
overnight at 4 °C at 0.05mg/mL in bicarbonate buffer. Upon block-
ing with PBS+0.5% gelatin (from cold water fish skin; Sigma-Aldrich,
Steinheim, Germany), the wells were incubated with two-fold dilu-
tions of the serum samples in 0.05% Tween®20 in PBS (PBST) and
incubated for 1h at RT. Upon washing with PBST, the wells were in-
cubated with a canine IgE-specific polyclonal antibody (horseradish
peroxidase-labelled, Novus Biologicals; Cambridge, UK, NB7346) for
1h at RT. Following PBST washes, ABTS solution (Roche Diagnostics;
Mannheim, Germany) was used as substrate. Finally, the optical density
(OD) was measured at 405nm with a spectrophotometer (Tecan Group
Ltd; Mannedorf, Switzerland).
2.3. Lymphocyte isolation
Isolation of peripheral blood mononuclear cells (PBMCs) from whole
blood was performed as described previously (de Bruin et al., 2007).
Briefly, blood (10mL) was incubated with 2mL of arabic gum/carbonyl
iron solution at 37 °C for one hour and gently turned every 10min.
Upon Ficoll density gradient centrifugation (600 g, 30min, RT), the in-
terphase was collected, diluted in an equal amount of Alsever’s solution
(2.05% D-dextrose (Serva, Heidelberg, Germany), 1% heat inactivated
fetal calf serum (hi-FCS) (Integro, Zaandam, The Netherlands), 100μg/
ml streptomycin/100 U/ml penicillin (P/S), 0.8% trisodium citrate di-
hydrate (Merck, Darmstadt, Germany), 0.055% water-free citric acid
(UCB Pharma, Leuven, Belgium) and 0.42% NaCl (VWR prolabo chem-
icals, Leuven, Belgium) in ultra pure water, pH 6.1) and centrifuged
at 550 g for 15min. RBC were lysed with lysis buffer (0.747% NH4Cl
(VWR) and 0.206% Tris (VWR) in distilled water, pH 7.2) and the re-
maining cells were washed with PBS and finally resuspended in 1mL
PBS. The cell concentration was determined with a hemocytometer and
the cell suspension was adjusted with PBS to a concentration of 5×10⁠6
cells/mL.
2.4. Lymphocyte stimulation and flow cytometry staining
To detect proliferating lymphocytes, cells were labelled with Cell-
Trace Violet (CellTrace™ Violet Cell Proliferation Kit, Life technolo-
gies, Carlsbad, CA, USA) following the manufacturer’s instructions.
The labelled cells were resuspended in complete medium (RPMI 1640
(Life technologies, Gibco®, Ghent, Belgium) with 10% hi-FCS, 1% P/
S, 1% L-glutamine (Life technologies), 1% Non-Essential Amino Acids
(Life technologies,), 1% sodium pyruvate (Life technologies), 0.5% gen-
tamycine (Life technologies) and 0.1% β-mercaptoethanol (UCB
Pharma)) at a concentration of 5×10⁠6 cells/mL and 100μL of this
cell suspension was added to a flat-bottomed 96-well plate (Greiner
bio-one, Frickenhausen, Germany) (de Bruin et al., 2007). Cells were
then stimulated with allergen extracts (pork, chicken, beef, cow’s milk,
fish, rice, wheat and corn at concentrations of 25µg/mL; Greer lab-
oratories; Lenoir, NC, USA), concanavalin
A (10µg/mL; Amersham Pharmacia Biotech; Freiburg, Germany) or
medium.
The PBMCs were then incubated at 37 °C in a 5% CO2 humidi-
fied atmosphere for five days and subsequently collected and stained
with a mixture of three fluorochrome-conjugated primary anti-dog an-
tibodies (AbD Serotec, Oxford, UK). This mixture contains FITC-con-
jugated anti-dog CD3, R-Phycoerythrin-conjugated anti-dog CD4 and
Alexa Fluor 647-conjugated anti-dog CD8. As a control, PBMCs were
also stained with fluorochrome-conjugated isotype-matched antibodies
(AbD Serotec). After doublet and dead cell exclusion with the live/dead
marker 7-aminoactinomycin D (7-AAD, Life technologies), the CD3+T
cell subpopulations were analysed using a BD FACSAria™ III Cell Sorter
(BD Biosciences, San Jose, CA, USA) and BD FACSDiva software (BD
Biosciences). The gating strategy is shown in Fig. 1.
2.5. Statistical analyses
For between-group comparisons, the Kruskal–Wallis test was em-
ployed, whereas for paired analysis of parameters before and after in-
tervention within groups the Wilcoxon signed-rank test was used. Corre-
lation between T cell subpopulations and clinical scores were analysed
with a Spearman correlation test (q). Statistical analyses were con-
ducted with SPSS Statistics 24 software (IBM; Armonk, NY, USA). A
p-value < 0.05 was considered significant.
3. Results and discussion
To assess if FA-SLIT affects the function of canine T cell subpopula-
tions, peripheral blood lymphocytes of dogs in the treatment group were
stimulated with food allergens in a recall assay and the resulting pheno-
type of the CD3+T cell subpopulations was investigated by flow cytom-
etry. The percentage of the CD4-CD8+ and CD4+CD8+T cells signif-
icantly decreased after the treatment (p=0.007 and p=0.004, respec-
tively), while the percentage of the CD4-CD8- T cell subset increased
(p=0.009) (Fig. 2A). As shown in Fig. 2B, proliferating CD4-CD8- dou-
ble-negative (DN) T cells were significantly increased after the treat-
ment (p=0.001), while the percentage of proliferating CD4-CD8+ and
CD4+CD8+ double-positive (DP) T cells was significantly decreased af-
ter the treatment (p=0.002 and p=0.019, respectively). There was no
difference in the percentage of proliferating CD4+CD8- T cells. The DN
T cell subset was reported to have an inflammatory function, being in-
volved in the development of autoimmune diseases and infections, as
well as a suppressive function, preventing allograft rejection, graft-ver-
sus-host disease, and autoimmune diabetes (Chen et al., 2003b; Cowley
et al., 2010; Hillhouse et al., 2010; Marlies et al., 2007; Reinhardt and
Melms, 2000; Young KJ et al., 2003). Given our results, we speculate
that this DN T cell subset activated by sublingual immunotherapy com-
prises regulatory T cells (Tregs). DN Tregs are unique antigen-specific
regulatory cells able to suppress CD8+ and CD4+ effector T cell re-
sponses and control the function of B cells, NK cells and dendritic cells
via multiple mechanisms, including the secretion of IFN-γ and IL-10
(Chen et al, 2003a; Chen et al., 2005, 2007; Ford et al., 2002; Gao et al.,
2011; He et al., 2007; Hillhouse et al., 2010; Ma et al., 2007). The role
of this T cell subset in tolerance induction has been investigated only in
one study, which demonstrated that DN T cells mediate the suppressive
effects of immunotherapy by inhibiting IgE production and attenuating
clinical signs in a mouse model of type I allergy (Raker et al., 2015).
In our study, the increased percentage of DN Treg was not followed by
significant changes in allergen-specific IgE concentration (Table 1), but
it was concurrent with a significant decrease of the CD8+T cell per-











E. Maina et al. Veterinary Immunology and Immunopathology xxx (xxxx) xxx-xxx
Fig. 1. Gating strategy to identify proliferating T cell subsets.a,b) Doublet cells were discriminated in forward scatter area (FSC)-A/FSC-H and side scatter area (SSC)-A/SSC-H dot plots.
c) Based on their size and granularity, the lymphocytes within the singlet cell population were gated in a FSC/SSC dot plot. d) Living lymphocytes were gated based on a 7-AAD staining.
e) Within the living lymphocyte gate, CD3+T cells were selected. f,g) Based on CellTrace Violet, proliferating cells were identified. h) within proliferating and resting T cells, four subsets
were identified based on CD4 and CD8 expression.
follow a different mechanism. Future research should include additional
markers to distinguish this regulatory T cell subpopulation from other
CD4-CD8- T cells.
Interestingly, also the CD4+CD8+ DP T cells were affected by the
treatment. These CD4+CD8+ DP T cells have been described in other
species, including pigs and humans. In swine, DP T cells are a mul-
tifunctional memory T cell subset involved in protection against vi-
ral infections (Gerner et al., 2015; Okutani et al., 2018), while in hu-
mans this T cell subset is associated with chronic diseases, including
atopic dermatitis (Bang et al., 2001; Overgaard et al., 2015). Only a
few reports describe these CD4+CD8+ DP T cells in dogs and they
seem to have an activated phenotype (Bismarck et al., 2012, 2014;
Hoshino et al., 2008; Kato et al., 2007; McGill et al., 2018), but their
function remains largely unclear. Recently, canine CD4+CD8+ DP
T cells were shown to expand upon infection with
Ehrlichia chaffeensis, an obligate intracellular bacterium causing chronic
infections in dogs (McGill et al., 2018). In our study, dogs with AFR had
a higher baseline value of DP T cells than that reported in healthy dogs
(25% vs 2.4%, resp.) and this baseline value decreased after the treat-
ment, suggesting that DP T cells may have a role in the pathogenesis of
AFR. This hypothesis is supported by a recent report demonstrating that
the absolute number of DP T cells in lungs and mediastinal lymph nodes
increased after immunization with OVA in mice with OVA-induced al-
lergic asthma compared to healthy subjects. This suggests that the re-
cruitment of DP T cells to sites of allergen-induced inflammation may
be involved in the pathogenesis of allergic asthma (Zuśka-Prot et al.,
2016). Together, these previous and our findings seem to indicate that
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Fig. 2. Enumeration of the percentages of the (A) total and (B) proliferating CD3+T cell
subpopulations before and after the treatment in allergen-restimulated PBMCs of dogs in
the treatment group (cases 4, 6, 8, 9 and 11). Since the responses were the same irrespec-
tive of the allergen, for dogs allergic to more than one food component only the average
of all culprit allergens is displayed (for dog 4 the average of the values for Pk,R,W,B,C,
and Mi is displayed; for dog 6 the average of the values for C and Fi; for dogs 8 and 9,
allergic to only one food component [C]; and for dog 11 the average of the values for C,B,
and W is displayed). Abbreviations: B, beef; C, chicken; Fi, fish; Mi, cow milk; Pk, pork; R,
rice; W, wheat. The horizontal lines correspond to the median value. Statistical analysis:
Wilcoxon signed-rank test: * P<0.05, ** P<0.01, and *** P<0.001.
Table 1
Allergen-specific serum IgE levels were measured before (pre) and after (post) FA-SLIT in
dogs included in the treatment group. The serum IgE levels are presented as OD values.
Dog allergens allergen-specific IgE
pre post






6 chicken 0.445 0.429
fish 0.222 0.270
8 chicken 0.170 0.243
9 chicken 0.227 0.163
11 chicken 0.382 0.363
wheat 0.241 0.443
beef 0.227 0.233
Despite these changes, the percentages of the total and proliferat-
ing T cell subpopulations and their changes after therapy were not cor-
related with changes in clinical scores (pVAS and CADESI; Maina and
Cox, 2016). The most plausible explanation could be a lack of statistical
power. To show this correlation between changes in T cell populations
and changes in clinical scores, more animals should have been included
in the study. Nevertheless, FA-SLIT appears to modulate the immune
system, resulting in a functional switch from an activated T cell profile
to a regulatory one, suggesting tolerance induction. We are the first to
report that CD4+CD8+ DP T cells are increased in dogs with adverse
food reactions and that food-specific immunotherapy seems to decrease
this subset and increase the percentage of DN T cells. However, future
studies should be performed to better elucidate the role of the DP and
DN T cell subsets in the pathogenesis of AFR as well as the mechanisms
of FA-SLIT.
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